Figure 3.

Comparison of A, percentage of patients with renal function preservation (RFP) and B, mean change in glycated haemoglobin (HbA1c) between patients treated with sodium‐glucose co‐transporter‐2 (SGLT2) inhibitors or dipeptidyl peptidase‐4 (DPP‐4) inhibitors in the overall database. RFP was defined as an increase or no change in estimated glomerular filtration rate between the baseline and follow‐up values. The adjusted mean difference in HbA1c was calculated as the between‐group difference in the mean change between the baseline and follow‐up values. aΔ, adjusted mean difference; aOR, adjusted odds ratio; CI, confidence interval.